ID   ADA10_RAT               Reviewed;         749 AA.
AC   Q10743; A0A0G2K562;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2018, sequence version 2.
DT   24-JUL-2024, entry version 174.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 10;
DE            Short=ADAM 10;
DE            EC=3.4.24.81 {ECO:0000250|UniProtKB:O14672};
DE   AltName: Full=Kuzbanian protein homolog;
DE   AltName: Full=Mammalian disintegrin-metalloprotease;
DE   AltName: CD_antigen=CD156c;
DE   Flags: Precursor;
GN   Name=Adam10; Synonyms=Madm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8694785; DOI=10.1042/bj3170045;
RA   Howard L., Mitchell S., Lu X., Griffiths S., Glynn P.;
RT   "Molecular cloning of MADM: a catalytically active mammalian disintegrin-
RT   metalloprotease expressed in various cell types.";
RL   Biochem. J. 317:45-50(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-279 AND ASN-440, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
CC   -!- FUNCTION: Transmembrane metalloprotease which mediates the ectodomain
CC       shedding of a myriad of transmembrane proteins, including adhesion
CC       proteins, growth factor precursors and cytokines being essential for
CC       development and tissue homeostasis. Associates with six members of the
CC       tetraspanin superfamily TspanC8 which regulate its exit from the
CC       endoplasmic reticulum and its substrate selectivity (By similarity).
CC       Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-|-Val-77'
CC       to its mature soluble form. Responsible for the proteolytical release
CC       of soluble JAM3 from endothelial cells surface. Responsible for the
CC       proteolytic release of several other cell-surface proteins, including
CC       heparin-binding epidermal growth-like factor, ephrin-A2, CD44, CDH2 and
CC       for constitutive and regulated alpha-secretase cleavage of amyloid
CC       precursor protein (APP). Contributes to the normal cleavage of the
CC       cellular prion protein. Involved in the cleavage of the adhesion
CC       molecule L1 at the cell surface and in released membrane vesicles,
CC       suggesting a vesicle-based protease activity (By similarity). Controls
CC       also the proteolytic processing of Notch and mediates lateral
CC       inhibition during neurogenesis (By similarity). Responsible for the
CC       FasL ectodomain shedding and for the generation of the remnant ADAM10-
CC       processed FasL (FasL APL) transmembrane form. Also cleaves the
CC       ectodomain of the integral membrane proteins CORIN and ITM2B (By
CC       similarity). Mediates the proteolytic cleavage of LAG3, leading to
CC       release the secreted form of LAG3 (By similarity). Mediates the
CC       proteolytic cleavage of IL6R and IL11RA, leading to the release of
CC       secreted forms of IL6R and IL11RA (By similarity). Enhances the
CC       cleavage of CHL1 by BACE1 (By similarity). Cleaves NRCAM (By
CC       similarity). Cleaves TREM2, resulting in shedding of the TREM2
CC       ectodomain (By similarity). Involved in the development and maturation
CC       of glomerular and coronary vasculature (By similarity). During
CC       development of the cochlear organ of Corti, promotes pillar cell
CC       separation by forming a ternary complex with CADH1 and EPHA4 and
CC       cleaving CADH1 at adherens junctions (By similarity). May regulate the
CC       EFNA5-EPHA3 signaling (By similarity). Regulates leukocyte
CC       transmigration as a sheddase for the adherens junction protein VE-
CC       cadherin/CDH5 in endothelial cells (By similarity).
CC       {ECO:0000250|UniProtKB:O14672, ECO:0000250|UniProtKB:O35598}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endopeptidase of broad specificity.; EC=3.4.24.81;
CC         Evidence={ECO:0000250|UniProtKB:O14672};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O14672};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:O14672};
CC   -!- ACTIVITY REGULATION: Catalytically inactive when the propeptide is
CC       intact and associated with the mature enzyme (By similarity). The
CC       disintegrin and cysteine-rich regions modulate access of substrates to
CC       exerts an inhibitory effect on the cleavage of ADAM10 substrates (By
CC       similarity). {ECO:0000250|UniProtKB:O14672,
CC       ECO:0000250|UniProtKB:Q10741}.
CC   -!- SUBUNIT: Forms a ternary EFNA5-EPHA3-ADAM10 complex mediating EFNA5
CC       extracellular domain shedding by ADAM10 which regulates the EFNA5-EPHA3
CC       complex internalization and function, the cleavage occurs in trans,
CC       with ADAM10 and its substrate being on the membranes of opposing cells.
CC       Interacts with the clathrin adapter AP2 complex subunits AP2A1, AP2A2,
CC       AP2B1, and AP2M1; this interaction facilitates ADAM10 endocytosis from
CC       the plasma membrane during long-term potentiation in hippocampal
CC       neurons (By similarity). Forms a ternary complex composed of ADAM10,
CC       EPHA4 and CADH1; within the complex, ADAM10 cleaves CADH1 which
CC       disrupts adherens junctions (By similarity). Interacts with EPHA2 (By
CC       similarity). Interacts with NGF in a divalent cation-dependent manner.
CC       Interacts with TSPAN14; the interaction promotes ADAM10 maturation and
CC       cell surface expression. Interacts with TSPAN5, TSPAN10, TSPAN14,
CC       TSPAN15, TSPAN17 and TSPAN33; these interactions regulate ADAM10
CC       substrate specificity, endocytosis and turnover (By similarity).
CC       Interacts (via extracellular domain) with TSPAN33 (via extracellular
CC       domain) and (via cytoplasmic domain) with AFDN; interaction with
CC       TSPAN33 allows the docking of ADAM10 to zonula adherens through a
CC       PDZ11-dependent interaction between TSPAN33 and PLEKHA7 while
CC       interaction with AFDN locks ADAM10 at zonula adherens (By similarity).
CC       Interacts with DLG1; this interaction recruits ADAM10 to the cell
CC       membrane during long-term depression in hippocampal neurons (By
CC       similarity). Interacts (via extracellular domain) with BACE1 (via
CC       extracellular domain) (By similarity). Interacts with FAM171A1 (By
CC       similarity). {ECO:0000250|UniProtKB:O14672,
CC       ECO:0000250|UniProtKB:O35598}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O14672};
CC       Single-pass type I membrane protein {ECO:0000305}. Golgi apparatus
CC       membrane {ECO:0000250|UniProtKB:O14672}; Single-pass type I membrane
CC       protein {ECO:0000305}. Cytoplasmic vesicle, clathrin-coated vesicle
CC       {ECO:0000250|UniProtKB:O14672}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:O35598}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:O35598}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:O14672}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O14672}. Note=Is localized in the plasma
CC       membrane but is also expressed in the Golgi apparatus and in clathrin-
CC       coated vesicles derived likely from the Golgi (By similarity). During
CC       long term depression, it is recruited to the cell membrane by DLG1 (By
CC       similarity). The immature form is mainly located near cytoplasmic
CC       fibrillar structures, while the mature form is predominantly located at
CC       zonula adherens and the cell membrane (By similarity). The localization
CC       and clustering of mature ADAM10 to zonula adherens is regulated by
CC       AFDN, TSPAN33, PLEKHA7 and PDZD11 (By similarity).
CC       {ECO:0000250|UniProtKB:O14672, ECO:0000250|UniProtKB:O35598}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, kidney, lung, spleen, ovary and
CC       testis.
CC   -!- DOMAIN: The Cys-rich region C-terminal to the disintegrin domain
CC       functions as a substrate-recognition module, it recognizes the EFNA5-
CC       EPHA3 Complex but not the individual proteins. Both Cys-rich and stalk
CC       region are necessary for interaction with TSPAN5, TSPAN10, TSPAN14,
CC       TSPAN17, TSPAN33. Stalk region is sufficient for interaction with
CC       TSPAN15. {ECO:0000250|UniProtKB:P62080, ECO:0000250|UniProtKB:Q10741}.
CC   -!- DOMAIN: The propeptide keeps the metalloprotease in a latent form via a
CC       cysteine switch mechanism. This mechanism may be mediated by a highly
CC       conserved cysteine (Cys-173) in the propeptide, which interacts and
CC       neutralizes the zinc-coordinating HEXGHXXGXXHD catalytic core of the
CC       metalloprotease domain. The dissociation of the cysteine from the zinc
CC       ion upon the activation-peptide release activates the enzyme.
CC       {ECO:0000250|UniProtKB:P03956}.
CC   -!- PTM: The precursor is cleaved by furin and PCSK7.
CC       {ECO:0000250|UniProtKB:Q10741}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z48444; CAA88359.1; -; mRNA.
DR   EMBL; AABR07070609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474041; EDL84174.1; -; Genomic_DNA.
DR   EMBL; AABR07070614; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07070613; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07070612; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07070611; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07070610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; S52477; S52477.
DR   RefSeq; NP_062127.1; NM_019254.1.
DR   AlphaFoldDB; Q10743; -.
DR   SMR; Q10743; -.
DR   STRING; 10116.ENSRNOP00000073306; -.
DR   MEROPS; M12.210; -.
DR   GlyCosmos; Q10743; 4 sites, No reported glycans.
DR   GlyGen; Q10743; 4 sites.
DR   iPTMnet; Q10743; -.
DR   PhosphoSitePlus; Q10743; -.
DR   SwissPalm; Q10743; -.
DR   PaxDb; 10116-ENSRNOP00000021066; -.
DR   Ensembl; ENSRNOT00000083255.2; ENSRNOP00000073306.1; ENSRNOG00000054257.2.
DR   Ensembl; ENSRNOT00055010887; ENSRNOP00055008470; ENSRNOG00055006672.
DR   Ensembl; ENSRNOT00060032187; ENSRNOP00060026199; ENSRNOG00060018682.
DR   Ensembl; ENSRNOT00065027331; ENSRNOP00065021462; ENSRNOG00065016421.
DR   GeneID; 29650; -.
DR   KEGG; rno:29650; -.
DR   UCSC; RGD:2032; rat.
DR   AGR; RGD:2032; -.
DR   CTD; 102; -.
DR   RGD; 2032; Adam10.
DR   eggNOG; KOG3658; Eukaryota.
DR   GeneTree; ENSGT00940000160579; -.
DR   InParanoid; Q10743; -.
DR   OrthoDB; 5395001at2759; -.
DR   PhylomeDB; Q10743; -.
DR   BRENDA; 3.4.24.81; 5301.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-RNO-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   PRO; PR:Q10743; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Proteomes; UP000234681; Chromosome 8.
DR   Bgee; ENSRNOG00000054257; Expressed in ileum and 19 other cell types or tissues.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:SynGO-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0046930; C:pore complex; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO-UCL.
DR   GO; GO:0097060; C:synaptic membrane; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0097197; C:tetraspanin-enriched microdomain; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070573; F:metallodipeptidase activity; ISO:RGD.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IDA:RGD.
DR   GO; GO:1902945; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:0008237; F:metallopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0034332; P:adherens junction organization; ISO:RGD.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:0034205; P:amyloid-beta formation; IMP:SynGO-UCL.
DR   GO; GO:0090102; P:cochlea development; ISO:RGD.
DR   GO; GO:0051089; P:constitutive protein ectodomain proteolysis; ISO:RGD.
DR   GO; GO:0038004; P:epidermal growth factor receptor ligand maturation; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0042117; P:monocyte activation; ISO:RGD.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0046931; P:pore complex assembly; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; ISO:RGD.
DR   GO; GO:0099173; P:postsynapse organization; ISO:RGD.
DR   GO; GO:0140249; P:protein catabolic process at postsynapse; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; ISO:RGD.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISO:RGD.
DR   GO; GO:0045670; P:regulation of osteoclast differentiation; NAS:RGD.
DR   GO; GO:0099175; P:regulation of postsynapse organization; ISO:RGD.
DR   GO; GO:1901342; P:regulation of vasculature development; ISO:RGD.
DR   GO; GO:0097327; P:response to antineoplastic agent; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0140448; P:signaling receptor ligand precursor processing; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd04270; ZnMc_TACE_like; 1.
DR   Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1.
DR   Gene3D; 4.10.70.10; Disintegrin domain; 1.
DR   InterPro; IPR034025; ADAM10_ADAM17.
DR   InterPro; IPR049038; ADAM10_Cys-rich.
DR   InterPro; IPR051489; ADAM_Metalloproteinase.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   PANTHER; PTHR45702; ADAM10/ADAM17 METALLOPEPTIDASE FAMILY MEMBER; 1.
DR   PANTHER; PTHR45702:SF4; DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 10; 1.
DR   Pfam; PF21299; ADAM10_Cys-rich; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF13574; Reprolysin_2; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; Blood coagulation inhibitor (disintegrin); 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection;
KW   Cleavage on pair of basic residues; Cytoplasm; Cytoplasmic vesicle;
KW   Disulfide bond; Glycoprotein; Golgi apparatus; Hydrolase; Membrane;
KW   Metal-binding; Metalloprotease; Notch signaling pathway; Phosphoprotein;
KW   Protease; Reference proteome; SH3-binding; Signal; Transmembrane;
KW   Transmembrane helix; Zinc; Zymogen.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..214
FT                   /evidence="ECO:0000250|UniProtKB:Q10741"
FT                   /id="PRO_0000029070"
FT   CHAIN           215..749
FT                   /note="Disintegrin and metalloproteinase domain-containing
FT                   protein 10"
FT                   /id="PRO_0000029071"
FT   TOPO_DOM        215..673
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        674..697
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        698..749
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          221..457
FT                   /note="Peptidase M12B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276"
FT   DOMAIN          458..552
FT                   /note="Disintegrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00068"
FT   REGION          705..749
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          735..749
FT                   /note="Interaction with AP2A1, AP2A2 and AP2M1"
FT                   /evidence="ECO:0000250|UniProtKB:O35598"
FT   MOTIF           171..178
FT                   /note="Cysteine switch"
FT   MOTIF           709..716
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           723..729
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        707..734
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        385
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         173
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P03956"
FT   BINDING         384
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   BINDING         388
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   BINDING         394
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   SITE            214..215
FT                   /note="Cleavage; by furin and PCSK7"
FT                   /evidence="ECO:0000250|UniProtKB:Q10741"
FT   MOD_RES         720
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   CARBOHYD        268
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        279
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        440
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        552
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        223..314
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        345..452
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        400..436
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        461..496
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        472..485
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        474..480
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        484..516
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        504..512
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        511..537
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        525..544
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        531..563
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        556..568
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        573..599
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        581..608
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        583..598
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        595..640
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        633..646
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
SQ   SEQUENCE   749 AA;  84087 MW;  7E506394D93A3095 CRC64;
     MVLPTVLILL LSWAAGLGGQ YGNPLNKYIR HYEGLSYNVD SLHQKHQRAK RAVSHEDQFL
     LLDFHAHGRQ FNLRMKRDTS LFSDEFKVET SNKVLDYDTS HIYTGHIYGE EGSFSHGSVV
     DGRFEGFIQT RGGTFYIEPA ERYIKDRILP FHSVIYHEDD INYPHKYGPQ GGCADHSVFE
     RMRKYQMTGV EEGTRAHSEE HAASMGPELL RKKRTTLAER NTCQLYIQTD HLFFKYYGTR
     EAVIAQISSH VKAIDTIYQT TDFSGIRNIS FMVKRIRINT TSDEKDPTNP FRFPNIGVEK
     FLELNSEQNH DDYCLAYVFT DRDFDDGVLG LAWVGAPSGS SGGICEKSKL YSDGKKKSLN
     TGIITVQNYG SHVPPKVSHI TFAHEVGHNF GSPHDSGTEC TPGESKNLGQ KENGNYIMYA
     RATSGDKLNN NKFSLCSIRN ISQVLEKKRN NCFVESGQPI CGNGMVEQGE ECDCGYSDQC
     KDECCFDANQ PEGKKCKLKP GKQCSPSQGP CCTAQCAFKS KSEKCRDDSD CAKEGICNGF
     TALCPASDPK PNFTDCNRHT QVCINGQCAG SICEKYDLEE CTCASSDGKD DKELCHVCCM
     KKMAPSTCAS TGSLQWNKQF NGRTITLQPG SPCNDFRGYC DVFMRCRLVD ADGPLARLKK
     AIFSPQLYEN IAEWIVAHWW AVLLMGIALI MLMAGFIKIC SVHTPSSNPK LPPPKPLPGT
     LKRRRPPQPI QQPPRQRPRE SYQMGHMRR
//
